SCHEMBL2318472

SCHEMBL2318472

CCCCCCCCCCCC(=O)NC1CCC(CCCCCCCCCCCC(N)=O)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 1/20 0.57
GNAO1 P09471 1/20 0.57
GNAI1 P63096 1/20 0.57
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
HPGD P15428 1/20 0.51
KMT2A Q03164 1/20 0.51
CNR1 P21554 10/20 0.50
CNR2 P34972 10/20 0.50
TRPV1 Q8NER1 4/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
NCOR2 Q9Y618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7543330 0.85 GNAI3 (0.53) GNAI3GNAO1GNAI1MEN1ALDH1A1
SCHEMBL1236493 0.85 GNAI3 (0.50) GNAI3GNAO1GNAI1MEN1ALDH1A1
SCHEMBL28340804 0.84 GNAI3 (0.75) GNAI3GNAO1GNAI1MEN1ALDH1A1
SCHEMBL1234276 0.84 GNAI3 (0.75) GNAI3GNAO1GNAI1MEN1ALDH1A1
SCHEMBL1457137 0.84 GNAI3 (0.75) GNAI3GNAO1GNAI1MEN1ALDH1A1
Hexadecanoic Acid Cyclopropylamide SCHEMBL1456457 0.84 GNAI3 (0.75) GNAI3GNAO1GNAI1MEN1ALDH1A1
SCHEMBL8361102 0.84 GNAI3 (0.75) GNAI3GNAO1GNAI1MEN1ALDH1A1
SCHEMBL11571826 0.84 GNAI3 (0.75) GNAI3GNAO1GNAI1MEN1ALDH1A1
SCHEMBL3551415 0.83 GNAI3 (0.72) GNAI3GNAO1GNAI1MEN1ALDH1A1
SCHEMBL13267848 0.82 CYP1A2 (0.48) GNAI3GNAO1GNAI1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110189117-A1 COSMETIC COMPOSITION CONTAINING A POLYORGANISILOXANE POLYMER L'OREAL (FR) 2011-08-04 US disclosed
US-7820146-B2 Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form L'OREAL S.A. (FR) 2010-10-26 US disclosed
US-20080057011-A1 Composition structured with a polymer containing a heteroatom and an Organogelator L'OREAL S.A., 2008-03-06 US disclosed
US-20050245673-A1 Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form L'OREAL S.A. (FR) 2005-11-03 US disclosed
US-20050201961-A1 Compositions containing a silicone resin film former and a silicone-containing copolymer L'OREAL (FR) 2005-09-15 US disclosed
US-20050158260-A1 Cosmetic composition containing a polyorganosiloxane polymer L'OREAL (FR) 2005-07-21 US disclosed
US-20040223987-A1 Composition structured with a polymer containing a heteroatom and organogelator L'OREAL S.A. (FR) 2004-11-11 US disclosed
US-6726915-B2 DIAMIDE COMPOUNDS RETAINING GOOD COSMETIC PROPERTIES, IN PARTICULAR A CERTAIN LEVEL OF L'OREAL (FR) 2004-04-27 US disclosed
US-20030129211-A9 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides L'OREAL S.A. (FR) 2003-07-10 US disclosed
US-20020150602-A1 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides LIVOREIL AUDE (FR) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080057011-A1 Composition structured with a polymer containing a heteroatom and an Organogelator CUTA, FABP4, PARG GNAI3 3467/4885GNAO1 4426/4885GNAI1 3638/4885
US-20040223987-A1 Composition structured with a polymer containing a heteroatom and organogelator CUTA, PARG, FABP4 GNAI3 3528/4885GNAO1 4473/4885GNAI1 3598/4885
US-20030129211-A9 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides FAAH, HRH1, HRH4 GNAI3 3751/4885GNAO1 3549/4885GNAI1 3336/4885
US-20020150602-A1 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides FAAH, HRH1, HRH4 GNAI3 3751/4885GNAO1 3549/4885GNAI1 3336/4885
US-20050201961-A1 Compositions containing a silicone resin film former and a silicone-containing copolymer RAD51, SMURF1, RER1 GNAI3 2610/4885GNAO1 3599/4885GNAI1 2366/4885
US-20110189117-A1 COSMETIC COMPOSITION CONTAINING A POLYORGANISILOXANE POLYMER CUTA, PRDX1, PRXL2A GNAI3 3591/4885GNAO1 2711/4885GNAI1 3407/4885
US-20050158260-A1 Cosmetic composition containing a polyorganosiloxane polymer SQLE, CUTA, FDFT1 GNAI3 3489/4885GNAO1 2652/4885GNAI1 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.